Pre-earnings options volume in Viking Therapeutics is normal with calls leading puts 9:2. Implied volatility suggests the market is anticipating a move near 8.8%, or $5.84, after results are released. Median move over the past eight quarters is 6.7%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VKTX:
- Viking Therapeutics management to meet virtually with Truist
- VKTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- LLY, VKTX, or NVO: Which Weight-Loss Drugmaker Could Gain the Best Returns?
- Viking Therapeutics Stock (NASDAQ:VKTX): Analysts Stay Bullish on 2024’s Top Mid-Cap
- 3 Best Stocks to Buy Now, 3/28/2024, According to Top Analysts